About 42% of American adults are obese, according to the U.S
Key Market Players Novo Nordisk A/S Eli Lilly and Company Sanofi S.A
doi: 7 Gholamian M, Farbood Y, Keshavarz M
Abstract Reactive species produced in the cell during normal cellular metabolism can chemically react with cellular biomolecules such as nucleic acids, proteins, and lipids, thereby causing their oxidative modifications leading to alterations in their compositions and potential damage to their cellular activities
Others are hesitant about injectables , evidenced in the anticipation around Eli Lillys oral candidate, orforglipron
The companies that recognize this reality and innovate accordingly will capture the greatest share of what promises to be one of the largest therapeutic markets in pharmaceutical history